Biotechs with Growing Cash Flow

 

1. Acorda Therapeutics (Nasdaq: ACOR)
2. Alkermes (Nasdaq: ALKS)
3. Alexion Pharmaceuticals (Nasdaq: ALXN)
4. Amgen (Nasdaq: AMGN)
5. Biogen-Idec (Nasdaq: BIIB)
6. BioMarin Pharmaceutical (Nasdaq: BMRN)
7. China Biologic Products (Nasdaq: CBPO)
8. Celgene (Nasdaq: CELG)
9. Emergent Biosolutions (NYSE: EBS)
10. Elan Corp. (NYSE: ELN)
11. Genomic Health (Nasdaq: GHDX)
12. Gilead Sciences (Nasdaq: GILD)
13. Myriad Genetics (Nasdaq: MYGN)
14. Onyx Pharmaceuticals (Nasdaq: ONXX)
15. Pharmacyclics (Nasdaq: PYCC)
16. PDL Biopharma (Nasdaq: PDLI)
17. Spectrum Pharmaceuticals (Nasdaq: SPPI)
18. United Therapeutics (Nasdaq: UTHR)
19. Vertex Pharmaceuticals (Nasdaq: VRTX)